Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Inge Henter

Showing results (71-80 of 201) with videos related to

Pageof 21
Sort By:
Acta Paediatrica (Oslo, Norway : 1992)|June 1, 2007
Kostmann syndrome or infantile genetic agranulocytosis, part two: Understanding the underlying genetic defects in severe congenital neutropeniaGöran Carlsson, Malin Melin, Niklas Dahl, et al.
Pediatric Blood & Cancer|August 19, 2009
Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosisDésirée Gavhed, Selma Olsson Akefeldt, Gustaf Osterlundh, et al.
Molecular Immunology|June 15, 2010
The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cellsXiaoli Feng, Jie Yan, Yibiao Wang, et al.
Journal of Periodontology|April 6, 2006
Periodontal disease in patients from the original Kostmann family with severe congenital neutropeniaGöran Carlsson, Ylva-Britt Wahlin, Anders Johansson, et al.
Frontiers in Pediatrics|July 18, 2022
Plasma Signaling Factors in Patients With Langerhans Cell Histiocytosis (LCH) Correlate With Relative Frequencies of LCH Cells and T Cells Within LesionsJenée Mitchell, Egle Kvedaraite, Tatiana von Bahr Greenwood, et al.
British Journal of Haematology|May 26, 2012
Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome/leukaemiaGöran Carlsson, Anders Fasth, Elisabet Berglöf, et al.
Cytokine|October 20, 2019
High levels of plasma interleukin-17A are associated with severe neurological sequelae in Langerhans cell histiocytosisMohamad Bachar Ismail, Selma Olsson Åkefeldt, Magda Lourda, et al.
Experimental Cell Research|April 1, 2014
Pathophysiology and spectrum of diseases caused by defects in lymphocyte cytotoxicityMarie Meeths, Samuel C C Chiang, Alexandra Löfstedt, et al.
Anti-Cancer Drugs|December 5, 2013
Bortezomib and IL-12 produce synergetic anti-multiple myeloma effects with reduced toxicity to natural killer cellsXiangling Wang, Xiaoli Feng, Juandong Wang, et al.
Pediatric Blood & Cancer|October 22, 2008
Treatment of the X-linked lymphoproliferative, Griscelli and Chédiak-Higashi syndromes by HLH directed therapyHelena Trottestam, Karin Beutel, Marie Meeths, et al.
Pageof 21

Showing results (71-80 of 201) with videos related to

Sort By:
Pageof 21
Acta Paediatrica (Oslo, Norway : 1992)|June 1, 2007
Kostmann syndrome or infantile genetic agranulocytosis, part two: Understanding the underlying genetic defects in severe congenital neutropeniaGöran Carlsson, Malin Melin, Niklas Dahl, et al.
Pediatric Blood & Cancer|August 19, 2009
Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosisDésirée Gavhed, Selma Olsson Akefeldt, Gustaf Osterlundh, et al.
Molecular Immunology|June 15, 2010
The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cellsXiaoli Feng, Jie Yan, Yibiao Wang, et al.
Journal of Periodontology|April 6, 2006
Periodontal disease in patients from the original Kostmann family with severe congenital neutropeniaGöran Carlsson, Ylva-Britt Wahlin, Anders Johansson, et al.
Frontiers in Pediatrics|July 18, 2022
Plasma Signaling Factors in Patients With Langerhans Cell Histiocytosis (LCH) Correlate With Relative Frequencies of LCH Cells and T Cells Within LesionsJenée Mitchell, Egle Kvedaraite, Tatiana von Bahr Greenwood, et al.
British Journal of Haematology|May 26, 2012
Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome/leukaemiaGöran Carlsson, Anders Fasth, Elisabet Berglöf, et al.
Cytokine|October 20, 2019
High levels of plasma interleukin-17A are associated with severe neurological sequelae in Langerhans cell histiocytosisMohamad Bachar Ismail, Selma Olsson Åkefeldt, Magda Lourda, et al.
Experimental Cell Research|April 1, 2014
Pathophysiology and spectrum of diseases caused by defects in lymphocyte cytotoxicityMarie Meeths, Samuel C C Chiang, Alexandra Löfstedt, et al.
Anti-Cancer Drugs|December 5, 2013
Bortezomib and IL-12 produce synergetic anti-multiple myeloma effects with reduced toxicity to natural killer cellsXiangling Wang, Xiaoli Feng, Juandong Wang, et al.
Pediatric Blood & Cancer|October 22, 2008
Treatment of the X-linked lymphoproliferative, Griscelli and Chédiak-Higashi syndromes by HLH directed therapyHelena Trottestam, Karin Beutel, Marie Meeths, et al.
Pageof 21